Chronic granulocytic leukemia with lymphadenopathy and leukemia cutis. 1982

K Padmanabhan, and R Subramanian, and C V Vaidyanathan

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease

Related Publications

K Padmanabhan, and R Subramanian, and C V Vaidyanathan
September 1983, Journal of the American Academy of Dermatology,
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
January 1978, Chemotherapy,
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
March 1981, American journal of clinical pathology,
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
May 1980, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
March 1977, Journal of the Tennessee Medical Association,
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
September 1970, American journal of clinical pathology,
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
May 1984, The Medical clinics of North America,
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
September 1976, The Medical clinics of North America,
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
May 1972, Wiadomosci lekarskie (Warsaw, Poland : 1960),
K Padmanabhan, and R Subramanian, and C V Vaidyanathan
January 1953, The American journal of pathology,
Copied contents to your clipboard!